1033809-93-6

Basic information

• Product Name: 2,3-dihydro-7-hydroxy-2-Methyl-1H-Isoindol-1-one
• Synonyms: 2,3-dihydro-7-hydroxy-2-Methyl-1H-Isoindol-1-one;7-hydroxy-2-methylisoindolin-1-one
• CAS NO: 1033809-93-6
• Molecular Formula: C9H9NO2
• Molecular Weight: 163.17326
• Mol File: 1033809-93-6.mol

Chemical Properties

• Boiling Point: 366.1±42.0 °C(Predicted)
• Appearance: /
• Density: 1.310±0.06 g/cm3(Predicted)
• PKA: 8.39±0.20(Predicted)
• CAS DataBase Reference: 2,3-dihydro-7-hydroxy-2-Methyl-1H-Isoindol-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-dihydro-7-hydroxy-2-Methyl-1H-Isoindol-1-one(1033809-93-6)
• EPA Substance Registry System: 2,3-dihydro-7-hydroxy-2-Methyl-1H-Isoindol-1-one(1033809-93-6)

Safety Data

• Hazardous Substances Data: 1033809-93-6(Hazardous Substances Data)

Usage

Derivative of isoindoline

This compound is derived from the isoindoline structure, which is a type of organic compound.

Class of organic compounds

Indoles This compound belongs to the class of organic compounds known as indoles, which are a group of chemical compounds that include a heterocyclic aromatic ring.

Physical appearance

White to off-white solid This describes the appearance of the compound in its solid state.

Molecular weight

163.17 g/mol This is the mass of one mole of the compound, measured in grams.

Use in organic synthesis and pharmaceutical research

Building block for the production of various drugs and bioactive molecules This compound is used as a building block in the synthesis of other compounds, including drugs and bioactive molecules.

Structure

Contains a hydroxyl group, a methyl group, and a dihydrofuran ring This describes the specific functional groups and structural features of the compound.

Therapeutic potential

Studied for its potential therapeutic applications This compound has been researched for its potential use in the treatment of various diseases and conditions.

Upstream product

• 761440-06-6 7-amino-2-methylisoindolin-1-one 
• 6520-83-8 ethyl 2-methoxy-6-methylbenzoate 
• 86823-81-6 6-bromomethyl-2-methoxy-benzoic acid ethyl ester 

Relevant articles and documents

DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED PATHOLOGIES

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds are disclosed that are represented by general formula (I). Also disclosed, are pharmaceutical compositions including these compounds and methods of using these compounds and compositions for the

NEW COMPOUNDS

The present invention encompasses compounds of general formula (1) wherein A, B, X, R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and t

FUSED HETEROCYCLIC COMPOUND

The present invention provides a fused heterocyclic compound having a tyrosine kinase inhibitory action, which is represented by the formula: wherein R1 is a hydrogen atom, a halogen atom, or an optionally substituted group bonded via a carbon atom, a nitrogen atom or an oxygen atom; R2 is a hydrogen atom, or an optionally substituted group bonded via a carbon atom or a sulfur atom, or R1 and R2, or R2 and R3 are optionally bonded to each other to form an optionally substituted ring structure; R3 is a hydrogen atom or an optionally substituted aliphatic hydrocarbon group, or R3 is optionally bonded to the carbon atom on ring A to form an optionally substituted ring structure; ring A is an optionally substituted benzene ring; and ring B is (i) an optionally substituted fused ring, or (ii) a pyridine ring having optionally substituted carbamoyl (the pyridine ring is optionally further substituted).